Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Thromboprophylaxis on Progression Free Survival of Patients With Advanced Pancreatic Cancer: The Pancreatic Cancer & Tinzaparin Prospective (imPaCT-PRO) Study

NCT05178628 is registered in ClinicalTrials.gov with Michalis Karamouzis as lead sponsor.

NCT NCT05178628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05178628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Thromboprophylaxis on Progression Free Survival of Patients With Advanced Pancreatic Cancer: The Pancreatic Cancer & Tinzaparin Prospective (imPaCT-PRO) Study
Lead sponsor
Michalis Karamouzis
Phase
Phase 3
Overall status
Unknown status
Start date
February 10, 2022
Completion date
December 31, 2024
Enrollment
450 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer, thromboembolism